SMARCA2 and neoplasm: When Brm was present, these chemically generated Trp53 mutations appeared to undergo selection pressure during tumor development, whereas those Trp53 mutations (typically in the DNA binding domain of Trp53) that lack functionality (Trp53- mediated transcription) were positively selected.